Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
573,621 4.500% |
-646,423 (-52.98%) |
Filing History |
| 2023-07-07 1:28 pm Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO | 543,325 4.310% |
-500,612 (-47.95%) |
Filing History |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 648,650 5.100% |
648,650 (New Position) |
Filing History |
| 2023-05-05 11:52 am Sale |
2023-04-30 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
1,220,045 9.700% |
-1,175,161 (-49.06%) |
Filing History |
| 2023-04-14 4:34 pm Purchase |
2023-04-04 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 820,149 6.500% |
820,149 (New Position) |
Filing History |
| 2023-02-09 4:01 pm Sale |
2022-12-31 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO | 1,043,937 8.330% |
-116,891 (-10.07%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 1,537,718 12.270% |
303,591 (+24.60%) |
Filing History |
| 2023-02-06 3:02 pm Sale |
2022-12-30 | 13G | Nektar Therapeutics NKTR |
Wellington Management Group LLP | 0 0.000% |
-758,915 (Position Closed) |
Filing History |
| 2023-02-02 3:19 pm Purchase |
2023-02-02 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
2,488,498 19.900% |
29,065 (+1.18%) |
Filing History |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
2,395,206 19.100% |
617,086 (+34.70%) |
Filing History |
| 2022-02-11 12:22 pm Purchase |
2022-02-11 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
2,459,433 20.000% |
95,636 (+4.05%) |
Filing History |
| 2022-02-10 12:26 pm Sale |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO | 1,160,828 9.430% |
-68,532 (-5.57%) |
Filing History |
| 2022-02-09 09:22 am Sale |
2022-02-08 | 13G | Nektar Therapeutics NKTR |
FMR LLC | 450,614 3.662% |
-180,440 (-28.59%) |
Filing History |
| 2022-02-04 09:29 am Sale |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
Wellington Management Group LLP | 758,915 6.170% |
-133,926 (-15.00%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
1,778,120 14.500% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
1,778,120 14.500% |
552,915 (+45.13%) |
Filing History |
| 2022-01-10 11:49 am Purchase |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 1,234,127 10.030% |
149,288 (+13.76%) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | Nektar Therapeutics NKTR |
FMR LLC | 631,054 5.128% |
-632,258 (-50.05%) |
Filing History |
| 2021-02-12 2:53 pm Purchase |
2021-02-12 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
2,363,797 19.800% |
255,188 (+12.10%) |
Filing History |
| 2021-02-12 12:02 pm Sale |
2009-02-28 | 13G | Nektar Therapeutics NKTR |
PRIMECAP MANAGEMENT CO | 1,229,360 10.280% |
-109,330 (-8.17%) |
Filing History |